Magnetic Resonance Image Guided Radiotherapy (MRIgRT) course

Key information

Next course dates

TBC

Registration opens

TBC

Location

ICR and RMH Sutton, SM2 5PT
See Sutton map at the bottom of our contacts page.

This course is organised by The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London.

Course outline

An opportunity to broaden your understanding of the capabilities and potential of MRI guidance in radiotherapy planning and treatment verification. We invite you to join us to hear from leading practitioners in the field, develop skills and share knowledge with other professionals involved in MRI in radiotherapy.

This two day course aims to improve understanding of MRIgRT, focusing on the knowledge and skills required to support current and future needs in radiotherapy.

The development of MRI in radiotherapy planning involves close communication with radiology and radiotherapy professionals. This course is aimed at all professionals involved in or interested in MRI for radiotherapy, including radiographers, physicists and clinicians.

Course Organisers: Dr Helen McNair, Ms Erica Scurr, Dr Shaista Hafeez, Miss Trina Herbert, and Professor Uwe Oelfke

"Great overall knowledge for all professions interested in MRI - extremely informative."
– Therapeutic Radiographer and course attendee

Course overview

The course will include taught and practical workshops to:

Improve understanding of the basic principles of MRI
Build foundation skills to support the increase in demand for MRI simulation
Develop practical skills
Learn about current clinical pathways and the latest research developments

The practical demonstrations will include:

MR simulation, image acquisition and interpretation, RT set up and safety.
Sequence and parameter manipulation
Adaptive workflow on the MR Linac

Provisional lecture list

The clinical need for MR in radiotherapy
Image contrast, Resolution and Factors affecting signal-to-noise
MR Simulation
MR planning workflow
MR-CT fusion planning
Image fusion and dosimetry
Safety considerations
Regional MR in RT – Pelvis,
Regional MR in RT, Abdomen (liver and pancreas)
Regional MR in RT, Breast
Managing motion (4D)
MR in Brachytherapy
MR Linac QA
Diffusion Weighted Imaging (DWI) principles and applications
Functional imaging

Programme overview

Previous comments from attendees

“I have now significantly more knowledge of potential for MRI in radiotherapy, its benefits and drawbacks.” – Clinical Oncologist

“MRI in radiotherapy planning is a lot more complicated than I thought. Highlighted that we would be crazy to do more MRI without an MRI physicist in the trust.” – Radiotherapy Physicist

“Excellent overview of MRI and how it is and will be used in the future.” – Radiotherapy Physicist

“Collaboration between diagnostic and Therapy radiographers is vital in MR planning.” – Therapeutic Radiographer

Accommodation

Accommodation is available in local hotels, details can be supplied upon request.

Further information

For further details on up to date course content call +44 (0)20 8661 3704 or email Cheryl Taylor.

Latest ICR News

Sentinal leadership team Georgia Mitsi, Chris Bakal, Matt de Vries

Precision oncology company Sentinal4D completes pre-seed funding round and launches to the public

20/12/24

Sentinal4D, a spinout company from The Institute of Cancer Research, London, has been announced to the public – having closed of its first round of funding and appointed its foundational leadership team.

See full story

ICR Carol service ceremony view of overhead in the chapel

Stars bring Christmas cheer to Carols from Chelsea

18/12/24 - Mernie Gilmore

Christmas arrived in style as celebrities and guests got into the festive spirit at Carols from Chelsea – raising more than £125,000 for The Institute of Cancer Research, London

See full story

Major trial shows prolonged benefit of olaparib in early-stage inherited breast cancer

12/12/24

One year of treatment with the targeted drug olaparib improves long-term survival in women with high-risk, early-stage breast cancer with mutations in BRCA1 or BRCA2 genes, new results from a major clinical trial show.

See full story

Breast cancer cell spheroid blue and purple

New understanding of aggressive form of breast cancer paves the way for tests and treatments

10/12/24

Scientists have developed a machine learning tool that can predict how an aggressive type of breast cancer will respond to treatment, and when it will return.

See full story